Fulgent Genetics, Inc.
FLGT
$18.59
$0.693.86%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.99% | -3.02% | -5.42% | -21.20% | -53.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.99% | -3.02% | -5.42% | -21.20% | -53.27% |
| Cost of Revenue | -4.60% | -8.77% | -15.26% | -18.91% | -26.70% |
| Gross Profit | 2.64% | 9.09% | 15.44% | -24.74% | -71.53% |
| SG&A Expenses | -4.69% | 9.56% | 0.53% | -5.63% | -5.86% |
| Depreciation & Amortization | 1.53% | 0.43% | -0.64% | 4.07% | 20.75% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.95% | 1.45% | -5.20% | -9.76% | -14.45% |
| Operating Income | 1.83% | -18.56% | 4.25% | -113.47% | -139.03% |
| Income Before Tax | 70.15% | -203.31% | -142.72% | -328.72% | -194.60% |
| Income Tax Expenses | -805.72% | -752.13% | 140.58% | 152.32% | -97.26% |
| Earnings from Continuing Operations | 74.99% | -164.64% | -240.30% | -530.34% | -223.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -85.00% | 374.88% | 390.47% | 365.16% | 400.95% |
| Net Income | 74.55% | -159.76% | -235.71% | -540.33% | -217.03% |
| EBIT | 1.83% | -18.56% | 4.25% | -113.47% | -139.03% |
| EBITDA | 0.33% | -39.73% | -9.30% | -4,776.29% | -121.79% |
| EPS Basic | 74.89% | -158.64% | -233.61% | -528.03% | -219.30% |
| Normalized Basic EPS | 6.14% | 14.71% | 47.47% | -46.04% | -121.50% |
| EPS Diluted | 74.90% | -157.14% | -231.94% | -517.64% | -224.13% |
| Normalized Diluted EPS | 6.14% | 14.71% | 47.52% | -42.28% | -122.31% |
| Average Basic Shares Outstanding | 1.51% | 0.90% | 0.42% | -0.28% | -1.05% |
| Average Diluted Shares Outstanding | 1.51% | 0.90% | -0.16% | -1.53% | -3.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
